scholarly journals Evaluation of serum cardiac troponin‐ I concentrations for diagnosis of infective endocarditis in dogs

Author(s):  
Eoin Kilkenny ◽  
Claire Watson ◽  
Joanna Dukes‐McEwan ◽  
Elizabeth F. Bode ◽  
Melanie J. Hezzell ◽  
...  

CHEST Journal ◽  
2000 ◽  
Vol 118 (2) ◽  
pp. 342-347 ◽  
Author(s):  
Giuseppe Boriani ◽  
Mauro Biffi ◽  
Vittorio Cervi ◽  
Gabriele Bronzetti ◽  
Giorgia Magagnoli ◽  
...  


1998 ◽  
Vol 272 (1) ◽  
pp. 59-67 ◽  
Author(s):  
Fred S. Apple ◽  
Scott W. Sharkey ◽  
Alireza Falahati ◽  
Maryann Murakami ◽  
Naheed Mitha ◽  
...  


2001 ◽  
Vol 28 (3) ◽  
pp. 277-282 ◽  
Author(s):  
P Morandi ◽  
PA Ruffini ◽  
GM Benvenuto ◽  
L La Vecchia ◽  
G Mezzena ◽  
...  


2017 ◽  
Vol 59 (3) ◽  
pp. 167-173 ◽  
Author(s):  
E. Dutton ◽  
N. Carmichael ◽  
U. Michal ◽  
P. J. Cripps ◽  
A. Boswood


2017 ◽  
Vol 19 (1) ◽  
pp. 1-13 ◽  
Author(s):  
E. Dutton ◽  
J. Dukes-McEwan ◽  
P.J. Cripps


2021 ◽  
Vol 23 (Supplement_D) ◽  
Author(s):  
Salma M Thabet ◽  
Marwa Meshaal ◽  
Yasser Yazied ◽  
Yasser Sharaf

Abstract Aim The aim of this study is to assess the prognostic value of cardiac troponin I as a predictor of in-hospital morbidity and mortality in patients with infective endocarditis. Methods This study included 48 patients with definite and possible IE according to modified Duke’s criteria for diagnosis of IE. This prospective longitudinal study was conducted on patients admitted to the cardiovascular department of Cairo University hospitals. All patients were subjected to full history taking and clinical examination, all laboratory and radiological investigations which included chest radiography, echocardiogram and other diagnostic procedures as needed for diagnosis and follow-up of IE were done with emphasis on cardiac troponin I level on admission. Results Troponin I was found to be statistically significant predictor for heart failure (NYHA III/IV), septic pulmonary embolism and in-hospital mortality in infective endocarditis patients by univariate and multivariate regression analysis with P values 0.023, 0.037and 0.002 respectively. Tricuspid valve vegetations had showed significant relation to troponin I levels with p value 0.033. Also it was found that SOFA score on first day of admission showed significant relation to troponin I level with P value 0.045 and 0.004 for prediction of hospital stay duration. Shock and intracranial hemorrhage showed borderline significance with P values 0.097, 0.069. On other hand, troponin I as predictor of pulmonary edema, mechanical complications, systemic embolization, acute kidney injury and presence of aortic root abscess had no statistical significance in our studied patients. Conclusions This study showed that there is as significant predictive value of elevated cardiac troponin I with heart failure, septic pulmonary embolism and all cause in-hospital mortality. In addition, it was significant predictor of the length of hospital stay, lymphocytosis and SOFA score. These results are emphasizing that cTn I level may predict higher risk patients who would need early and aggressive control of infection medically alone or combined with surgery in IE patients.





1999 ◽  
Vol 45 (7) ◽  
pp. 1018-1025 ◽  
Author(s):  
Qinwei Shi ◽  
Mingfu Ling ◽  
Xiaochen Zhang ◽  
Minyuan Zhang ◽  
Lilly Kadijevic ◽  
...  

Abstract Background: Up to a 20-fold variation in serum cardiac troponin I (cTnI) concentration may be observed for a given patient sample with different analytical methods. Because more limited variation is seen for control materials and for purified cTnI, we explored the possibility that cTnI was present in altered forms in serum. Methods: We used four recombinantly engineered cTnI fragments to study the regions of cTnI recognized by the Stratus®, Opus®, and ACCESS® immunoassays. The stability of these regions in serum was analyzed with Western blot. Results: The measurement of several control materials and different forms of purified cTnI using selected commercial assays demonstrated five- to ninefold variation. Both the Stratus and Opus assays recognized the N-terminal portion (NTP) of cTnI, whereas the ACCESS assay recognized the C-terminal portion (CTP) of cTnI. Incubation of recombinant cTnI in normal human serum produced a marked decrease in cTnI concentration as determined with the ACCESS, but not the Stratus, immunoassay. Western blot analysis of the same samples using cTnI NTP- and CTP-specific antibodies demonstrated preferential degradation of the CTP of cTnI. Conclusions: The availability of serum cTnI epitopes is markedly affected by the extent of ligand degradation. The N-terminal half of the cTnI molecule was found to be the most stable region in human serum. Differential degradation of cTnI is a key factor in assay-to-assay variation.



Sign in / Sign up

Export Citation Format

Share Document